Skip to main content
SpringerLink
Log in

Novel all-oral hep C treatments deliver in US

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Rein DB, et al. Projected Health and Economic Impact of Hepatitis C on the United States Veterans Administration Health System from 2014 to 2024. 49th Annual Meeting of the European Association for the Study of the Liver : abstr. P785, 9 Apr 2014.

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Novel all-oral hep C treatments deliver in US. PharmacoEcon Outcomes News 703, 6 (2014). https://doi.org/10.1007/s40274-014-1260-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-014-1260-x

Search

Navigation